Patient Engagement Synapse
  • Join now
  • Login
COVID-19 hub
  • Home
  • People
  • Organizations
  • Initiatives
  • Events
  • Resources
  • Conditions
  • Trainings
  • Patient Pledge
    • Take the Pledge
    • The Pledge Record
  • Reports
  • Join now
  • Login

Lupus

Rheumatology
  • Overview
  • Organizations 6
  • People 2
  • Initiatives 6
  • Resource 1
  • Events 0

An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.


Synonyms

lupus , lupus erythematosus

Related diseases

BSLE , CNS lupus , Chilblain lupus type 2 , DILE , DLE , Rowell syndrome , SAMHD1 chilblain lupus , SLE - lupus erythematosus, systemic , SLE, pediatric onset , SLEB12 , SLEB13 , SLEB14 , SLEB15 , SLEB3 , SLEB4 , SLEB5 , SLEB6 , SLEB7 , SLEB8 , SLEH1 , SLEN1 , SLEN2 , SLEN3 , STAT4 systemic lupus erythematosus (disease) , TLR5 systemic lupus erythematosus (disease) , TREX1 chilblain lupus , autosomal SLE , autosomal systemic lupus erythematosus , bullous systemic lupus erythematosus , central nervous system lupus , Display more information chilblain lupus , chilblain lupus 1 , chilblain lupus 2 , chilblain lupus caused by mutation in SAMHD1 , chilblain lupus caused by mutation in TREX1 , chilblain lupus type 1 , chronic cutaneous lupus erythematosus , cutaneous lupus erythematosus , cutaneous lupus erythematosus, chronic , discoid lupus erythematosus , disseminated lupus erythematosus , drug induced lupus , drug induced lupus erythematosus , drug-induced lupus , drug-induced lupus erythematosus , familial SLE , familial chilblain lupus , familial systemic lupus erythematosus , hereditary Chilblain lupus , hereditary chilblain lupus , hereditary systemic lupus erythematosus (disease) , hypertrophic or verrucous lupus erythematosus , intermittent cutaneous lupus , let , lupus erythematosus and erythema multiforme-like syndrome , lupus erythematosus panniculitis , lupus erythematosus profundus , lupus erythematosus tumidus , lupus erythematosus, systemic , lupus panniculitis , lupus profundus , neonatal lupus erythematosus , neonatal systemic lupus erthematosus , pediatric systemic lupus erythematosus , subacute cutaneous lupus erythematosus , systemic lupus erythematosus , systemic lupus erythematosus (disease) , systemic lupus erythematosus (disease) caused by mutation in STAT4 , systemic lupus erythematosus (disease) caused by mutation in TLR5 , systemic lupus erythematosus type 16 , systemic lupus erythematosus, susceptibility to, 1 , systemic lupus erythematosus, susceptibility to, 11 , systemic lupus erythematosus, susceptibility to, type 1 , systemic lupus erythematosus, susceptibility to, type 11 Display less info
see all

Organizations

EULAR European League Against Rheumatism

Global
1 User
1 Initiative
3 Resources

International Foundation for Autoimmune & Autoinflammatory Arthritis (IFAA)

Patient Advocacy Organization

Global
1 User
0 Initiatives
0 Resources

Leapcure

Patient Advocacy Organization

Global
1 User
0 Initiatives
0 Resources

Lupus Europe

Patient Advocacy Organization

Europe
1 User
0 Initiatives
0 Resources

Lupus Foundation of America

United States
0 Users
0 Initiatives
1 Resource

OMERACT

Europe
1 User
1 Initiative
0 Resources

People

Dawn Richards

Clinical Trials Ontario

Pledge icon
IP

Ingrid Pansar

Global Medical Liaison - BKZ development team

Brussels, Belgium

UCB

Initiatives

Coach. Leader. Friend - An End-to-end Solution for Lupus Patients in a Clinical Trial.

UCB

Global

Lupus Patient Protocol Simulation

AstraZeneca

North America

Recommendations for Patient Research Partners Involvement

OMERACT
MD

Global

Resources

TF
MV

Alleati per la Salute_presentation

19 May 2020 Other

Do you need help?

  • Contact us
  • Help Center
  • Latest updates
  • Cookie privacy options

Useful links

  • About us
  • Features
  • Search tool
  • Terms and Conditions
  • Privacy Policy
  • Geographical
  • Medical scope
  • Timeline
  • Patient matrix
  • Medicine lifecycle

Join our newsletter

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.

5.1.1@staging
© Copyright SYNAPSE 2021. All Rights Reserved Powered by The Synergist.